Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men
Authors:
- Iris Bs ChenICIris Bs Chen
- Matthew B. ConnorMCMatthew B. Connor
- William ClarkeWCWilliam Clarke
- Mark A. MarzinkeMMMark A. Marzinke
- Vanessa Bs CummingsVCVanessa Bs Cummings
- Autumn BreaudABAutumn Breaud
- Jessica M. FogelJFJessica M. Fogel
- Oliver LaeyendeckerOLOliver Laeyendecker
- Sheldon D. PhD FieldsSFSheldon D. PhD Fields
- Deborah DonnellDDDeborah Donnell
- Sam Mat GriffithSGSam Mat Griffith
- Hyman M. ScottHSHyman M. Scott
- 1 August 2015
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 69 (4) , 446-452
Abstract
Background: HIV Prevention Trials Network (HPTN) 061 enrolled black men who have sex with men in the United States. Some men with low/undetectable HIV RNA had unusual patterns of antiretroviral (ARV) drug use or had drugs detected in the absence of viral suppression. This report includes a comprehensive analysis of ARV drug use and drug resistance among men in HPTN 061 who were not virally suppressed. Methods: The analysis included 169 men who had viral loads >400 copies per milliliter at enrollment, including 3 with acute infection and 13 with recent infection. By self-report, 88 were previously diagnosed, including 31 in care; 137 men reported no ARV drug use. Samples from these 169 men and 23 seroconverters were analyzed with HIV genotyping and ARV drug assays. Results: Forty-eight (28%) of the 169 men had ≥1 drug resistance mutation (DRM); 19 (11%) had multiclass resistance. Sixty men (36%) had ≥1 ARV drug detected, 42 (70%) of whom reported no ARV drug use. Nine (23%) of 39 newly infected men had ≥1 DRM; 10 had ≥1 ARV drug detected. Unusual patterns of ARV drugs were detected more frequently in newly diagnosed men than previously diagnosed men. The rate of transmitted drug resistance was 23% based on HIV genotyping and self-reported ARV drug use but was 12% after adjusting for ARV drug detection. Conclusions: Many men in HPTN 061 had drug-resistant HIV, and many were at risk of acquiring additional DRMs. ARV drug testing revealed unusual patterns of ARV drug use and provided a more accurate estimate of transmitted drug resistance.Keywords
This publication has 27 references indexed in Scilit:
- Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061PLOS ONE, 2013
- Adherence and Acceptability in MTN 001: A Randomized Cross-Over Trial of Daily Oral and Topical Tenofovir for HIV Prevention in WomenAIDS and Behavior, 2012
- HIV-1 Antiretroviral ResistanceDrugs, 2012
- Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008AIDS Research and Treatment, 2012
- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment FailureJAMA, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006AIDS, 2010
- Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infectionAIDS, 2007
- Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based PopulationsPain Medicine, 2007
- Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistanceAIDS, 2007